UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
276.21
-16.48 (-5.63%)
At close: Mar 20, 2026
UCB SA Market Cap
UCB SA has a market cap or net worth of $54.28 billion as of March 20, 2026. Its market cap has increased by 44.55% in one year.
Market Cap
54.28B
Enterprise Value
54.15B
Revenue
9.09B
Ranking
n/a
PE Ratio
29.67
Stock Price
$276.21
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 54.28B, an increase of 4,421.00%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 54.28B | 1.98% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 348.74M |
| Northwest Biotherapeutics | 325.20M |
| Silence Therapeutics | 313.16M |
| Vaxart | 152.72M |
| BioStem Technologies | 86.48M |
| HST Global | 70.72M |
| Nuo Therapeutics | 67.12M |
| Vicapsys Life Sciences | 48.56M |